B007

· Shanghai Jiaolian Drug Research and Development Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for B007, covering 2024-10-10 to 2025-03-25. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy. [Phase 2, Phase 3]